References
- Stocks J., Gutteridge J.M.C., Sharp R.J., Dormandy T.L. Assay using brain homogenate for measuring the antioxidant activity of biological fluids. Clinical Science and Molecular Medicine 1974; 47: 215–222
- Stocks J., Gutteridge J.M.C., Sharp R.J., Dormandy T.L. The inhibition of lipid autooxidation by human serum and its relationship to serum proteins and alpha-tocopherol. Clinical Science and Molecular Medicine 1974; 47: 223–233
- Gutteridge J.M.C., Quinlan G.J. Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: The important primary role for iron-binding and iron-oxidising proteins. Biochimica et Biophysica Acta 1993; 1156: 144–150
- Gutteridge J.M.C., Paterson S.K., Segal A.W., Halliwell B. Inhibition of lipid peroxidation by the iron-binding protein lactoferrin. Biochemical Journal 1981; 199: 259–261
- Weinberg E.D. The iron-with-holding defense system. Am. Soc. Microbiol News 1993; 59: 559–562
- Iron and infection. Molecular, Physiological and Clinical Aspects, J.J. Bullen, E. Griffiths. Wiley, Chichester 1987
- Gutteridge J.M.C., Stocks J. Caeruloplasmin: physiological and pathological perspectives. Critical Reviews in Clinical Laboratory Sciences 1981; 14: 257–329
- Osaki S., Johnson D.A., Frieden F. The possible significance of the ferrous oxidase activity of caeruloplasmin in normal human serum. Journal of Biological Chemistry 1966; 241: 2746–2751
- Reilly C.A., Sorlie M., Aust S.D. Evidence for a protein-protein complex during iron loading into ferritin by ceruloplasmin. Archives of Biochemistry and Biophysics 1998; 354: 165–171
- Gutteridge J.M.C. Antioxidant properties of ceruloplasmin towards iron and copper-dependent oxygen radical formation. Federation of European Biochemical Societies Letters 1983; 157: 37–40
- Kim I.G., Park S.Y., Kim K.C., Yum J.J. Thiollinked peroxidase activity of human ceruloplasmin. Federation of European Biochemical Societies Letters 1998; 431: 473–475
- Gutteridge J.M.C. Reduction of low molecular mass iron by reducing molecules present in plasma and the protective action of ceruloplasmin. Journal of Trace Elements and Electrolytes in Health and Disease 1991; 5: 279–281
- Benzie I.F.F., Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: The FRAP assay. Analytical Biochemistry 1996; 239: 70–76
- Pepper J.R., Mumby S., Gutteridge J.M.C. Transient iron-overload with bleomycin-detectable iron present during cardiopulmonary bypass surgery. Free Radical Research 1994; 21: 53–58
- Evans P.J., Evans R., Kovar I.Z., Holten A.F., Halliwell B. Bleomycin detectable iron in the plasma of premature and full-term neonates. Federation of European Biochemical Societies Letters, 303: 210–212
- Lindemann J.H.N., Houdkamp E., Lentjes E.G.W., Poorthuis B.J.H., Berger H.M. Limited protection against iron-induced lipid peroxidation by cord blood plasma. Free Radical Research 1992; 16: 285–294
- Lindemann J.H.N., von Zoeren-Grobben D., Schrijver J., Speck A.J., Poorthuis B.J.H., Berger H.M. The total free radical trapping ability of cord blood plasma in preterm and term babies. Pediatric Research 1989; 26: 20–24
- Pepper J.R., Mumby S., Gutteridge J.M.C. Blood cardioplegia increases plasma iron overload and thiol levels during cardiopulmonary bypass. Annals of Thoracic Surgery 1995; 60: 1735–1740
- Pepper J.R., Mumby S., Gutteridge J.M.C. Sequential oxidative damage, and changes in iron-binding and iron-oxidising plasma antioxidants during cardiopulmonary bypass surgery. Free Radical Research 1994; 21: 377–385
- Symons M.C.R., Gutteridge J.M.C. Free Radicals and Iron: Chemistry, Biology and Medicine. Oxford University Press, Oxford 1998
- Sies H. Oxidative Stress II. Oxidants and Antioxidants. Academic Press, London 1991